pioglitazone and nadp
pioglitazone has been researched along with nadp in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Backman, JT; Jaakkola, T; Laitila, J; Neuvonen, PJ | 1 |
| Bränström, R; Dey, D; Forsberg, L; Lu, M; Sjöholm, A; Zhang, F; Zhang, Q | 1 |
| Hasegawa, T; Okada, K; Okita, Y; Pinsky, DJ | 1 |
| Dolenec, P; Mršić-Pelčić, J; Pilipović, K; Župan, G; Župan, Ž | 1 |
| Cheng, Z; Ding, H; Landry, AP | 1 |
Other Studies
5 other study(ies) available for pioglitazone and nadp
| Article | Year |
|---|---|
Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Hypoglycemic Agents; In Vitro Techniques; Microsomes, Liver; NADP; Pioglitazone; Thiazolidinediones | 2006 |
BLX-1002, a novel thiazolidinedione with no PPAR affinity, stimulates AMP-activated protein kinase activity, raises cytosolic Ca2+, and enhances glucose-stimulated insulin secretion in a PI3K-dependent manner.
Topics: AMP-Activated Protein Kinases; Animals; Calcium; Cells, Cultured; Cytosol; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Fenofibrate; Glucose; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; KATP Channels; Mice; Mice, Inbred Strains; NADP; Obesity; Peroxisome Proliferator-Activated Receptors; Phosphatidylinositol 3-Kinases; Pioglitazone; Protein Kinase Inhibitors; Signal Transduction; Thiazolidinediones; Time Factors; Tissue Culture Techniques; Up-Regulation | 2009 |
Antioxidant properties of pioglitazone limit nicotinamide adenine dinucleotide phosphate hydrogen oxidase and augment superoxide dismutase activity in cardiac allotransplantation.
Topics: Animals; Graft Survival; Heart Transplantation; Hypoglycemic Agents; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; NADP; Oxidative Stress; Pioglitazone; PPAR gamma; Reperfusion Injury; Superoxide Dismutase; Thiazolidinediones; Transplantation, Homologous; Vascular Diseases | 2011 |
A single dose of PPARγ agonist pioglitazone reduces cortical oxidative damage and microglial reaction following lateral fluid percussion brain injury in rats.
Topics: Animals; Brain Edema; Brain Injuries; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Lipid Peroxidation; Male; Microglia; NADP; Neuroprotective Agents; Oxidative Stress; Percussion; Pioglitazone; Rats; Rats, Wistar; Thiazolidinediones | 2015 |
Reduction of mitochondrial protein mitoNEET [2Fe-2S] clusters by human glutathione reductase.
Topics: Animals; Escherichia coli; Escherichia coli Proteins; Ethylmaleimide; Gene Expression; Glutathione Reductase; Humans; Hydrogen Peroxide; Iron-Sulfur Proteins; Mice; Mitochondria, Heart; Mitochondrial Membranes; Mitochondrial Proteins; Myocardium; NADP; Oxidation-Reduction; Pioglitazone; Rats; Recombinant Proteins; Thiazolidinediones; Thioredoxin-Disulfide Reductase | 2015 |